Evidence map›Paper›PMID 33626880›Full record

ArticleASN neuro

Intermittent Lipopolysaccharide Exposure Significantly Increases Cortical Infarct Size and Impairs Autophagy.

Ashley E Russell, John Z Cavendish, Ali Rai, Mya Vannoy, Ahmad H Dakhlallah, Heng Hu, Xuefang Ren, Amal Amer, Candice M Brown, Clay B Marsh and 2 more

Open access · goldAbstract read
In one paragraph

Article in ASN neuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Ashley E RussellDepartment of Neuroscience, West Virginia University School of Medicine, Morgantown, United States.
John Z CavendishDepartment of Neuroscience, West Virginia University School of Medicine, Morgantown, United States.
Ali RaiDepartment of Biomedical Engineering, West Virginia University School of Medicine, Morgantown, United States.
Mya VannoyDepartment of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine, Morgantown, United States.
Ahmad H DakhlallahDepartment of Biology, West Virginia University School of Medicine, Morgantown, United States.
Heng HuRockerfeller Center for Neuroscience, West Virginia University School of Medicine, Morgantown, United States.
Xuefang RenDepartment of Neuroscience, West Virginia University School of Medicine, Morgantown, United States.
Amal AmerDepartment of Microbial Infection and Immunity, Infectious Diseases Institute, Ohio State University, Columbus, United States.
Candice M BrownDepartment of Neuroscience, West Virginia University School of Medicine, Morgantown, United States.ORCID 0000-0001-5845-0221
Clay B MarshRobert C. Byrd Health Sciences Center, West Virginia University School of Medicine, Morgantown, United States.
James W SimpkinsDepartment of Neuroscience, West Virginia University School of Medicine, Morgantown, United States.
Duaa DakhlallahDepartment of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine, Morgantown, United States.ORCID 0000-0002-6288-4927
West Virginia University · USThe Ohio State University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
West Virginia University Stroke COBREP20GM109098 · NIGMS · WEST VIRGINIA UNIVERSITY · PI DEVRIES, ANNE COURTNEY · 2014 to 2024
$24.5M
Unraveling the role of the CFTR ion channel in susceptibility to SARS-CoV-2 infection and inflammationR01AI124121 · NIAID · OHIO STATE UNIVERSITY · PI AMER, AMAL O, CORMET-BOYAKA, ESTELLE A · 2016 to 2020
$3.7M
Stroke and Alzheimers Disease Related DementiasT32AG052375 · NIA · WEST VIRGINIA UNIVERSITY · PI Paul D Chantler, BERNARD G. SCHREURS · 2017 to 2026
$3.5M
NIAID NIH HHS R01 AI124121NIA NIH HHS T32 AG052375NIGMS NIH HHS P20 GM109098NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

Globally, stroke is a leading cause of death and disability. Traditional risk factors like hypertension, diabetes, and obesity do not fully account for all stroke cases. Recent infection is regarded as changes in systemic immune signaling, which can increase thrombosis formation and other stroke risk factors. We have previously shown that administration of lipopolysaccharide (LPS) 30-minutes prior to stroke increases in infarct volume. In the current study, we found that animals intermittently exposed to LPS have larger cortical infarcts when compared to saline controls. To elucidate the mechanism behind this phenomenon, several avenues were investigated. We observed significant upregulation of tumor necrosis factor-alpha (TNF-α) mRNA, especially in the ipsilateral hemisphere of both saline and LPS exposed groups compared to sham surgery animals. We also observed significant reductions in expression of genes involved in autophagy in the ipsilateral hemisphere of LPS stroke animals. In addition, we assessed DNA methylation of autophagy genes and observed a significant increase in the ipsilateral hemisphere of LPS stroke animals. Intermittent exposure to LPS increases cortical infarct volume, downregulates autophagy genes, and induces hypermethylation of the corresponding CpG islands. These data suggest that intermittent immune activation may deregulate epigenetic mechanisms and promote neuropathological outcomes after stroke.

Indexed as

LipopolysaccharidesTumor Necrosis Factor-alphaAnimalsAutophagyInfarctionRNA, MessengerLipopolysaccharidesRNA, MessengerTumor Necrosis Factor-alphaautophagyDNA methylationLPSstrokeTNF-α

Identifiers

PMID33626880
PMCPMC8020222
OpenAlexW3130943696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.